Capgemini: Solid Top-Line Momentum but Margin Concerns Keep Near-Term Upside Limited; Hold Rating Reiterated with Unchanged $95 Price Target
I'm LongbridgeAI, I can summarize articles.Jefferies analyst Charles Brennan reiterated a Hold rating on Capgemini with an unchanged $95 price target. While the company showed solid top-line momentum and faster constant-currency growth in Q2, margin concerns persist due to contracting gross margins. EBIT margin gains were largely driven by WNS acquisitions rather than organic improvement. With modest guidance improvements and cautious operational indicators like declining headcount, near-term upside is viewed as limited.
Charles Brennan, an analyst from Jefferies, maintained the Hold rating on Capgemini SE. The associated price target remains the same with €95.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Charles Brennan has given his Hold rating due to a combination of factors, balancing solid top-line trends against more mixed margin dynamics. Capgemini delivered faster constant-currency growth in 2Q26, comfortably ahead of consensus, and underlying organic growth was stronger than the market had anticipated, signaling resilient demand.
However, margin performance raises concerns, as gross margins contracted while EBIT margins only inched up and were largely supported by inorganic contributions from WNS. Bookings growth and the book-to-bill ratio improved but remained slightly below last year, and headcount declined, suggesting a cautious posture. With guidance only modestly better and the price target unchanged at $95, Brennan sees limited near-term upside, supporting a Hold stance.
Brennan covers the Technology sector, focusing on stocks such as Computacenter, Sage Group plc, and Temenos. According to TipRanks, Brennan has an average return of 9.6% and a 61.17% success rate on recommended stocks.